Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Niacin (as a Vasodilator), and a Topical Steroid (for Macular Edema), Non-Ischemic CRVO,HRVO,BRVO

NCT00493064 is registered in ClinicalTrials.gov with Palo Alto Medical Foundation as lead sponsor.

NCT NCT00493064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00493064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Niacin (as a Vasodilator), and a Topical Steroid (for Macular Edema), Non-Ischemic CRVO,HRVO,BRVO
Lead sponsor
Palo Alto Medical Foundation
Phase
Phase 2/3
Overall status
Completed
Start date
October 31, 2006
Completion date
October 31, 2016
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinal vein occlusion